Synapticure is revolutionizing the treatment landscape for ALS (Amyotrophic Lateral Sclerosis) patients by providing personalized medical care and advancing treatment options. Founded in 2019 and headquartered in Chicago, the company has grown to a team of 35 dedicated professionals. Their mission is to ensure all ALS patients have access to the highest quality care while simultaneously working to develop personalized treatments for different types of ALS. The company operates on a remote-first basis for many positions, offering competitive compensation packages. Synapticure represents a unique opportunity to join a healthcare technology company that's making a real difference in the lives of patients with neurodegenerative diseases. The company's focus on personalized medicine and commitment to advancing ALS treatment makes it an ideal place for professionals who want to contribute to meaningful healthcare innovation. With strong leadership from founders Martina de Majo, Peter Wallach, and Brian Wallach, Synapticure is well-positioned to transform the future of ALS care and treatment.